Polymeric Drug Delivery Devices: Role in Cornea and External Disease : Eye & Contact Lens

Secondary Logo

Journal Logo

Review Article

Polymeric Drug Delivery Devices: Role in Cornea and External Disease

Roy, Aravind M.B.B.S., M.S.; Krishna Venuganti, Venkata V. Ph.D.; Chauhan, Shreya S. M. Pharm.; Garg, Prashant M.B.B.S., M.S.

Author Information
Eye & Contact Lens: Science & Clinical Practice 48(3):p 119-126, March 2022. | DOI: 10.1097/ICL.0000000000000874


The field of ophthalmic drug delivery is undergoing rapid changes not only in the evolution of pharmacologic agents but also in the novel drug delivery vehicles. The ocular surface has limitations to drug penetration because of the presence of tight junctions between basal epithelial cells, which limits the amount of drug that can be absorbed after topical instillation. In addition, nasolacrimal drainage reduces the precorneal residence time significantly. Contact lenses (CLs) have been considered as possible carriers for topical medications because they reside on the ocular surface for a sufficient length of time, and pharmacologic agents may be copolymerized with hydrogels allowing controlled drug diffusion. This strategy reduces the frequency of dosage while improving compliance. Modification of drug delivery vehicles is essential to allow sustained release of the drug from a polymeric complex, facilitate stability and residence time of the drug on the precorneal tear film, and improve penetration into biologic membranes. This review focuses on updates in CL-based and non-CL–based strategies in ophthalmic drug delivery.

© 2021 Contact Lens Association of Ophthalmologists

You can read the full text of this article if you:

Access through Ovid